Browsing Tag
Granules India
11 posts
Granules India to acquire Senn Chemicals to expand CDMO business
Granules India Limited (BSE: 532482, NSE: GRANULES) has announced a strategic acquisition of Senn Chemicals AG, a Switzerland-based…
Granules India faces six observations after US FDA inspection at Gagillapur facility in Hyderabad
Granules India Limited has recently completed a US Food and Drug Administration (US FDA) inspection at its Gagillapur…
Granules India secures ANDA approval for Pantoprazole Sodium Tablets from FDA
Granules India Limited, a prominent player in the pharmaceutical industry, has announced that the US Food & Drug…
Granules India gains FDA approval for Sildenafil oral suspension ANDA
Granules India Limited has announced a major achievement with the US Food & Drug Administration (US FDA) approving…
Granules India gains FDA approval for Losartan-Hydrochlorothiazide Tablets
Granules India Limited proudly announced today that the United States Food & Drug Administration (US FDA) has granted…
Granules India subsidiary completes FDA PADE inspection with zero observations
Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of Granules India Limited, situated in Chantilly, Virginia, USA,…
Granules India gets FDA approval for generic epilepsy drug Levetiracetam
Granules India has announced its receipt of approval from the US Food and Drug Administration (FDA) for its…
FDA greenlights Granules India’s Metoprolol Succinate ER tablets
Granules India Limited announced its receipt of US Food and Drug Administration (FDA) approval for its Abbreviated New…
Granules India gets Venlafaxine ER Capsules FDA approval
Granules India has secured approval for its abbreviated new drug application (ANDA) for Venlafaxine Hydrochloride Extended-Release (ER) Capsules…
Granules India opens pharma packaging facility in Manassas, Virginia
Indian pharma company Granules India said that Granules Consumer Health (GCH), has opened and launched a pharma packaging…